BioSpace News Archive

Conceptions Reproductive Associates of Colorado (“Conceptions”), a leading fertility clinic in the U.S., has completed its integration of technology from TMRW Life Sciences (“TMRW”), which provides for the safe and sophisticated management of the precious frozen eggs and embryos that are central to most IVF procedures

Pressure BioSciences, Inc. (OTCQB: PBIO) today announced that the Company will host a teleconference to discuss its Fourth Quarter and Fiscal Year 2020 financial results and to provide a business update. Anyone interested may listen to the teleconference either live (by telephone) or through a replay

As Long COVID brings renewed attention to the debilitating and chronic illness known as Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a record number of advocates are virtually gathering on Capitol Hill for Solve M.E.'s 5th Annual Advocacy Week Monday, April 19.

Quadrant Biosciences Inc., a developer of novel molecular diagnostic tools, has been granted a Breakthrough Device designation by the Center of Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) for its innovative Clarifi ASD® autism saliva test.

David Hovland, Ph.D., to serve as Chief Regulatory Officer and Bryan Smith, J.D. as General Counsel, Corporate Secretary, and Chief Compliance Officer

Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced it will present at the BofA Securities 2021 Virtual Health Care Conference via web cast.

Allakos Inc. (the “Company” or “Allakos”) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) for the treatment of eosinophil and mast cell-related diseases, today announced that Baird Radford has been appointed Chief Financial Officer.

Potential First-in-Class Therapy for a Subset of Gastric and Gastroesophageal Cancers That Overexpress Fibroblast Growth Factor Receptor 2 (FGFR2b) Designation is Supported by Results From the Phase 2 FIGHT Trial

SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the limited commercial launch of its 3D-printed WaveForm TO (TLIF Oblique) Interbody System.

The issues raised by Relief Therapeutics in its release dated April 19, 2021 have no bearing on NeuroRx’s ability or commitment to deliver a safe, effective, and stable lifesaving drug on a worldwide basis.